SEATTLE, July 15, 2015 /PRNewswire/ -- NHS England has named MCG, through its sister company First Databank Europe (both part of the Hearst Health network), an approved vendor for its Clinical Utilization Review (CUR) initiative, one of several initiatives in its 2014-15 Commissioning for Quality and Innovation (CQUIN) payment framework. With access to CQUIN funding, participating English hospitals can now license MCG care guidelines and Indicia® interactive software to reduce inappropriate admissions, support efficient care progression and timely discharge, and improve care access and quality across the continuum.
Already a leading provider of evidence-based guidance and software to providers and health plans in the United States, with the approval from NHS England, Hearst Health has taken a major step in expanding the presence of its solutions internationally. NHS England, which oversees the budgeting, planning, and delivery of care throughout England, sees about 15 million inpatient admissions a year.
"For 25 years, we have been in the business of developing evidence-based care guidelines and interactive software that support the optimal delivery of appropriate care," says Jon Shreve, President of MCG. "Eight of the 10 largest health plans and more than 1,300 hospitals already use our solutions to drive effective care in the United States. We welcome the opportunity to bring these capabilities to the English health system."
NHS England introduced the CUR program to facilitate the adoption of utilization review technologies with the aim of optimizing care efficiency and quality in inpatient and critical care settings. Participating NHS Trusts can now secure CQUIN funding to develop cutting-edge clinical utilization review programs that will improve patient flow, enhance care quality, and ensure that patients receive the right level of care in the most appropriate setting.
The depth and breadth of MCG clinical guidance distinguishes it from other utilization review solutions. NHS England has specifically approved MCG's acute care content, Inpatient & Surgical Care and General Recovery Care, delivered through its Indicia interactive software, which was designed for quick and easy use in hospitals. MCG's team of clinical editors reviews more than 140,000 references each year as it updates and expands the care guidelines. The latest edition of the care guidelines cites more than 29,000 unique references.
About NHS England
Founded in 1948, the NHS provides free healthcare at the point of use to all residents of the United Kingdom. NHS England, which comprises the largest part of the overall system, is responsible for improving health outcomes for a population of 53.9 million. It employs more than 1.3 million, including 40,236 general practitioners (GPs), 351,446 nurses, 18,576 ambulance staff, and 111,963 hospital and community health service (HCHS) medical and dental staff. For more information about NHS England, visit www.england.nhs.uk.
MCG, now part of the Hearst Health network, independently develops and produces evidence-based clinical guidelines and software used by more than 2,200 clients, including 1,300 hospitals and eight of the ten largest U.S. health plans. Updated annually by an experienced team of clinicians, the care guidelines support the care management of a majority of Americans. For more information, visit MCG.
MCG is part of the Hearst Health network which also includes FDB (First Databank), Zynx Health, and Homecare Homebase. The mission of the Hearst Health network is to help guide the most important care moments by delivering vital information into the hands of everyone who touches a person's health journey. Each year in the U.S., care guidance from the Hearst Health network reaches 76% of discharged patients, 133 million insured individuals, 30 million home health visits, 1.88 billion retail pharmacy prescriptions and 3.26 billion prescription claims. Extensions of the Hearst Health network include Hearst Health Ventures and the Hearst Health Innovation Lab.
Tel +1 206 389 5405